Cargando…
Type I Interferons Keep Activated T Cells Alive
Antigen injection into animals causes antigen-specific T cells to become activated and, rapidly thereafter, die. This antigen-induced death is inhibited by inflammation. To find out how inflammation has this effect, various cytokines were tested for their ability to interfere with the rapid death of...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192920/ https://www.ncbi.nlm.nih.gov/pubmed/9927514 |
_version_ | 1782147348864958464 |
---|---|
author | Marrack, Philippa Kappler, John Mitchell, Tom |
author_facet | Marrack, Philippa Kappler, John Mitchell, Tom |
author_sort | Marrack, Philippa |
collection | PubMed |
description | Antigen injection into animals causes antigen-specific T cells to become activated and, rapidly thereafter, die. This antigen-induced death is inhibited by inflammation. To find out how inflammation has this effect, various cytokines were tested for their ability to interfere with the rapid death of activated T cells. T cells were activated in vivo, isolated, and cultured with the test reagents. Two groups of cytokines were active, members of the interleukin 2 family and the interferons (IFNs) α and β. This activity of IFN-α/β has not been described previously. It was due to direct effects of the IFNs on the T cells and was not mediated by induction of a second cytokine such as interleukin 15. IFN-γ did not slow the death of activated T cells, and therefore the activity of IFN-α/β was not mediated only by activation of Stat 1, a protein that is affected by both classes of IFN. IFN-α/β did not raise the levels of Bcl-2 or Bcl-(XL) in T cells. Therefore, their activity was distinct from that of members of the interleukin 2 family or CD28 engagement. Since IFN-α/β are very efficiently generated in response to viral and bacterial infections, these molecules may be among the signals that the immune system uses to prevent activated T cell death during infections. |
format | Text |
id | pubmed-2192920 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1999 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21929202008-04-16 Type I Interferons Keep Activated T Cells Alive Marrack, Philippa Kappler, John Mitchell, Tom J Exp Med Articles Antigen injection into animals causes antigen-specific T cells to become activated and, rapidly thereafter, die. This antigen-induced death is inhibited by inflammation. To find out how inflammation has this effect, various cytokines were tested for their ability to interfere with the rapid death of activated T cells. T cells were activated in vivo, isolated, and cultured with the test reagents. Two groups of cytokines were active, members of the interleukin 2 family and the interferons (IFNs) α and β. This activity of IFN-α/β has not been described previously. It was due to direct effects of the IFNs on the T cells and was not mediated by induction of a second cytokine such as interleukin 15. IFN-γ did not slow the death of activated T cells, and therefore the activity of IFN-α/β was not mediated only by activation of Stat 1, a protein that is affected by both classes of IFN. IFN-α/β did not raise the levels of Bcl-2 or Bcl-(XL) in T cells. Therefore, their activity was distinct from that of members of the interleukin 2 family or CD28 engagement. Since IFN-α/β are very efficiently generated in response to viral and bacterial infections, these molecules may be among the signals that the immune system uses to prevent activated T cell death during infections. The Rockefeller University Press 1999-02-01 /pmc/articles/PMC2192920/ /pubmed/9927514 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Articles Marrack, Philippa Kappler, John Mitchell, Tom Type I Interferons Keep Activated T Cells Alive |
title | Type I Interferons Keep Activated T Cells Alive |
title_full | Type I Interferons Keep Activated T Cells Alive |
title_fullStr | Type I Interferons Keep Activated T Cells Alive |
title_full_unstemmed | Type I Interferons Keep Activated T Cells Alive |
title_short | Type I Interferons Keep Activated T Cells Alive |
title_sort | type i interferons keep activated t cells alive |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192920/ https://www.ncbi.nlm.nih.gov/pubmed/9927514 |
work_keys_str_mv | AT marrackphilippa typeiinterferonskeepactivatedtcellsalive AT kapplerjohn typeiinterferonskeepactivatedtcellsalive AT mitchelltom typeiinterferonskeepactivatedtcellsalive |